Decreased expression of transforming growth factor beta receptors on head and neck squamous cell carcinoma tumor cells

American Journal of Surgery

Volumn 172, Issue 6, 1996, Pages 641-645

  Eisma, Roselle J ^a   Spiro, Jeffrey D ^a   Von Biberstein, S E ^a   Lindquist, Richard ^a   Kreutzer, Donald L ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1ALPHA; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; AGED; CANCER GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL LINE; DOWN-REGULATION; HEAD AND NECK NEOPLASMS; HUMANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0030442884     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(96)00305-4     Document Type: Conference Paper

References (20)

1. Norgaard P, Hougaard S, Poulsen HS, Spang-Thompsen M. Transforming Growth Factor ßand Cancer. Cancer Treatment Reviews. 1995;21:367-403.
2. Von Biberstein SE, Spiro JD, Lindquist RL, Kreutzer DL. Enhanced Tumor Cell Expression of Tumor Necrosis Factor Receptors in Head and Neck Squamous Cell Carcinoma. Am J Surg. 1995;170:416-422.
3. Von Biberstein SE, Spiro JD, Lindquist RL, Kreutzer DL. Interleukin-1 Receptor Antagonist in Head and Neck Squamous Cell Carcinoma. Arch Oto HNS. 1996;122:751-759.
4. Cohen RF, Contrino J, Spiro JD, et al. Interleukin 8 expression by head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1995;121:202-209.
5. Hoosein NM, McKnight MK, Levine AE, Mulder KM, Childress FF, Brattain DE. Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-ß1. Exp Cell Res. 1989;181:442-453.
6. Yan Z, Hsu S, Winawer S, Friedman D. Transforming growth factor TGF-ß1 inhibits retinoblastoma gene expression but not pRB phasphorylation in TGF-ß1 growth stimulated colon carcinoma cells. Oncogene. 1992;7:801-805.
7. Manning AM, Williams AC, Game SM, Pasakkeva C. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor (TGF-ß): Converstion of an Adenoma Cell line to a Tumorigenic Phenotype is accompanied a reduced response to the inhibitory effects of TGF-ß. Oncogene. 1991;6:1471-1476.
8. Kimchi A, Wang X-F, Weinberg RA, Chiefetz S, Massague J. Absence of TGF-ß receptors and growth inhibitory responses in retinoblastoma cells. Science. 1988;24:196-199.
9. Lewis CE, Leek R, Harris A, McGee JO'D. Cytokine regulation of angiogenesis in breast cancer: The role of tumor-associated macrophages. J Leukocyte Biol. 1995;57:747-751.
10. Strieter RM, Polverini PJ, Arenberg DA, Walz A, Opdenakker G, Van Damm J, Kunkel SL. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer (review). J Leukocyte Biol. 1995;57:752-762.
11. Veiweg J, Rosenthal FM, Bannerji R, Heston WD, Fair WR, Gansbacher B, Gilboa E. Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines. Cancer Res. 1994;54:1760-1765.
12. Mann EA, Spiro JD, Chen LL, Kreutzer DL. Cytokine expression in head and neck squamous cell carcinomas. Am J Surg. 1992;164:567-573.
13. Sporn MB, Roberts AB, Wakefield LM, de Cronbrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-ß J Cell Biol. 1987;195:597-641.
14. Derynck R, Jarett JA, Chen EY, Eaton DH, Bell JR, Assoian K, Roberts AB, Sporn MB, Goeddel DV. Human Transforming growth factor-ß complimentary DNA sequence and expression in normal and transformed cells. Nature. 1985;316:701-705.
15. Sporn MB, Roberts AB. Transforming growth factor-ß: multiple actions and potential clinical applications. JAMA. 1989;262:938-941.
16. Ruscetti FW, Palladino MA. Transforming Growth Factor-ß and the Immune System. Progr Growth Factor Res. 1991;3:159-175.
17. Filmus J, Kerbel RS. Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-ß during tumor progression. Curr Opin Oncol. 1993;5:123-129.
18. Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Sensibar JA, Kim JH, Kato M, Lee C. Genetic change in transforming growth factor ß (TGF-ß) receptor type I gene correlates with insensitivity to TGF-ß1 in human prostate cancer cells. Cancer Res. 1996;56:44-48.
19. Sun L, Gengfei W, Willson JKV, Zborowska E, Yang J, Rajkarunanayake I, Wang J, Gentry LE, Wang XF, Brattain MG. Expression of transforming growth factor ß type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem. 1994;269:26449-26455.
20. Sing GK, Ruscetti FW, Beckwith M, Keller JR, Ellingsworth L, Urba WJ, Longo DL. Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-ß mediated autocrine negative loop by phorbol myristate acetate. Cell Growth Differentiation. 1990;1:549-557.